Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica

Tanaz A Kermani1, Kenneth J Warrington2

  • 1Division of Rheumatology, David Geffen School of Medicine, University of California Los Angeles, 2020 Santa Monica Boulevard, Suite 540, Santa Monica, CA 90404, USA.

Insights

Polymyalgia rheumatica (PMR) is a common inflammatory condition in those over 50, causing pain and stiffness. Diagnosis relies on clinical factors, as specific tests are lacking, though ultrasonography shows promise.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) is a prevalent inflammatory disorder affecting individuals over 50.
  • Key symptoms include shoulder and hip girdle pain and significant morning stiffness.
  • Elevated inflammatory markers are common, complicating differential diagnosis with conditions like rheumatoid arthritis.

Purpose of the Study:

  • To review the diagnostic challenges and current understanding of Polymyalgia Rheumatica (PMR).
  • To highlight the association between PMR and giant cell arteritis (GCA).
  • To discuss recent advancements in diagnostic criteria and therapeutic approaches for PMR.

Main Methods:

  • Review of clinical presentation, diagnostic workup, and epidemiological data for PMR.
  • Analysis of the relationship between PMR and large-vessel vasculitis, including giant cell arteritis.
  • Evaluation of emerging diagnostic tools like ultrasonography and provisional classification criteria.

Main Results:

  • Distinguishing PMR from mimics like rheumatoid arthritis and spondyloarthropathy is a clinical challenge.
  • Subclinical large-vessel vasculitis is often detected in asymptomatic PMR patients via imaging.
  • Ultrasonography reveals synovitis and tenosynovitis, aiding PMR diagnosis.

Conclusions:

  • Current PMR diagnosis relies on a combination of clinical assessment, labs, and imaging due to lack of specific tests.
  • Provisional classification criteria have been developed by EULAR/ACR.
  • Glucocorticoid treatment is standard but associated with morbidity; novel biologic therapies are under investigation, and relapses remain common.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
484
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343